Explore
Dosage Form Formulation Technologies for Improving Bioavailability
0 Ungluers have
Faved this Work
Login to Fave
This Special Issue welcomed original research papers, but was not limited to cooperative works between academia and pharmaceutical companies where reformulations or original dosage form designs were performed. Papers or reviews including the principles of Quality by Design to improve the bioavailability of drugs belonging to BCS Classes of II or IV were warmly encouraged for submission. We were looking for manuscripts that optimized innovative technology through the design of experiments as well. Non-pharma institutes or departments and their innovative research projects were also invited to contribute to this Special Issue if their novel and original results could be adapted to dosage form formulation or production.
This book is included in DOAB.
Why read this book? Have your say.
You must be logged in to comment.
Rights Information
Are you the author or publisher of this work? If so, you can claim it as yours by registering as an Unglue.it rights holder.Downloads
This work has been downloaded 4 times via unglue.it ebook links.
- 4 - pdf (CC BY-NC-ND) at Unglue.it.
Keywords
- absorption enhancement
- alginate microbeads
- amorphous solid dispersion
- anticancer
- anticancer therapy
- antimicrobial therapy
- ayer-by-layer assembly
- BGP-15
- bioavailability
- bioavailability enhancement
- Biodegradation
- Box–Behnken design of experiment
- buffering
- caco-2 cells
- CaCO3 particles
- calcite
- calcium carbonate
- calcium ions
- cannabichromene
- cannabidiol
- cannabidiolic acid
- Cannabis
- carbon dioxide bubbles
- cavitation
- Cell culture
- centrifugal spinning
- cholesterol
- CK2 inhibitor DMAT
- controlled release
- degradation
- design of experiment
- design of experiment approach
- dissolution
- dissolution enhancement
- DOPAC
- DOPET
- ex vivo methods
- fast-dissolving film
- human volunteers
- HVA
- hyaluronic acid
- hydroxytyrosol
- hyperlipidemia
- in situ forming nanoparticles
- in vitro methods
- in vitro permeation
- itraconazole
- Labrafil M 2125 CS
- Labrasol ALF
- Lipid
- lipid-based formulations
- Metastability
- microbead
- microfibre
- MOPET
- oral bioavailability
- oral formulation
- ossification
- parenteral
- PBPK
- PDLG
- penetration enhancers
- periodontal pocket drug delivery
- periodontitis
- Permeability
- pH-sensitivity
- pharmaceutical formulation
- pharmacokinetics
- poloxamer 407
- polymer
- polyvinylpyrrolidone
- poorly water-soluble drug
- porcine skin
- Protein kinase CK2
- PVA
- PVP
- recrystallization
- resorption
- rosuvastatin
- solubility
- sucrose
- supersaturation
- tabletting
- Targeted Drug Delivery
- thema EDItEUR::M Medicine and Nursing
- thema EDItEUR::M Medicine and Nursing::MQ Nursing and ancillary services::MQP Pharmacy / dispensing
- theranostics
- thermoresponsive niosome gel
- Transcutol® HP
- transdermal patches
- US imaging
- vaterite
Links
DOI: 10.3390/books978-3-7258-1569-2Editions